Advertisement

Topics

HERMES Biosciences Company Profile

09:07 EST 17th December 2018 | BioPortfolio

HERMES Biosciences, Inc. was founded in 1998 to develop highly innovative targeted drug delivery technologies for therapeutic and other biomedical applications. The HERMES vision builds upon previous accomplishments by HERMES scientists and others in the development of both liposomes and antibodies as targeting agents. Liposomes have become an important drug delivery system, with several first- and second-generation products approved for clinical use in oncology and infectious disease. Monoclonal antibodies have similarly become an important form of treatment, including a number of clinically useful antibodies for cancer and other diseases. Previously, HERMES founders were involved in the successful commercial development of both liposome and monoclonal antibody drugs. Now, HERMES scientists are focused on developing the next generation of targeted agents featuring full integration of the complementary technologies of liposomes and monoclonal antibodies. This has resulted in the development of modularly assembled and molecularly targeted carrier systems. These novel agents are capable of delivering an array of small molecule drugs and probes, macromolecular agents, and nucleic acid therapeutics specifically to target cells. This represents a promising new approach for the diagnosis and treatment of cancer and other important diseases.

Location

61 Airport Blvd., Suite B
South San Francisco
California
94080.
United States of America

Contact

Phone: (650) 873-2583
Fax: (650) 873-2501


News Articles [597 Associated News Articles listed on BioPortfolio]

Biophysical Society announces Hermes Taylor-Weiner as its 18-19 Congressional Fellow

(Biophysical Society) The Biophysical Society (BPS) has selected Hermes Taylor-Weiner, Ph.D., as its 2018-19 Congressional Fellow.

Illumina to Acquire Pacific Biosciences for Approximately $1.2 Billion

Illumina, Inc. and Pacific Biosciences announced they have signed an agreement for Illumina to acquire Pacific Biosciences at a price of $8.00 per Pacific Biosciences share in an all-cash transaction....

Strategic partnership forms between Taconic Biosciences and Cyagen Biosciences

A strategic partnership has been formed between Taconic Biosciences and Cyagen Biosciences — both global companies that generate custom genetically engineered rodent models and associated services.

Illumina To Acquire Pacific Biosciences At $8.00/shr

SAN DIEGO (dpa-AFX) - Illumina, Inc. (ILMN) and Pacific Biosciences (PACB) announced an agreement for Illumina to acquire Pacific Biosciences at a price of $8.00 per Pacific Biosciences share in a...

Kuros Biosciences Ltd.: Kuros Biosciences appoints Strategic Advisory Board

Kuros Biosciences appoints Strategic Advisory Board Schlieren (Zurich), Switzerland, September 25, 2018 - Kuros Biosciences (SIX: KURN) today announced the formation of its Strategic Advisory Boar...

Kuros Biosciences Ltd.: Kuros Biosciences appoints Pascal Longlade as Chief Medical Officer

Kuros Biosciences appoints Pascal Longlade as Chief Medical Officer Schlieren (Zurich), Switzerland, August 23, 2018 Kuros Biosciences AG (SIX: KURN) announced today the appointment of Pascal Long...

FSD Pharma to acquire Therapix Biosciences

The transaction combines two highly-complementary businesses and creates a medical cannabis industry innovator focused on the research and development of advanced cannabinoid treatments. Therapix Bios...

Healthcare Background Screening Firm PreCheck Wins Four 2018 Hermes Creative Awards

PreCheck, a healthcare exclusive employment and background screening firm, was recognized as a Platinum and Gold winner during the 2018 Hermes Creative Awards international competition. HOUSTON (PRWEB...

Drugs and Medications [13 Associated Drugs and Medications listed on BioPortfolio]

Naturally nova scotia hand sanitizer [Owen Biosciences, Inc.]

Drug Facts

Anhydrous spf 30 [Owen Biosciences, Inc.]

Drug Facts

Anhydrous spf 30 [Owen Biosciences, Inc.]

Drug Facts

Natelle one [Azur Pharma, Inc.]

Natelle OneRx Prenatal Vitamin & Plant-Based DHA Now with 28 mg Iron

Natelle one [Azur Pharma, Inc.]

Natelle®OneRx Prenatal Vitamin & Plant-Based DHA

Clinical Trials [11 Associated Clinical Trials listed on BioPortfolio]

A Clinical Trial to Determine the Safety and Efficacy of Hope Biosciences Autologous Mesenchymal Stem Cell Therapy (HB-adMSCs) for the Treatment of Rheumatoid Arthritis

Hope Biosciences is conducting a research study of an investigational product called autologous adipose-derived mesenchymal stem cells (abbreviated as HB-adMSCs) as a possible treatment fo...

HepaStem Long-Term Safety Registry

All patients having received at least one infusion of the Investigational Medicinal Product (IMP) HepaStem HHALPC during a previous interventional clinical study conducted by Promethera Bi...

HERMES STUDY: Study on the Feasibility and Efficiency of Noninvasive Positive-Pressure Ventilation (NPPV) in Prehospital Care

The purpose of this study is determine if NPPV can be performed in a pre-hospital setting very early after onset of dyspnea with a similar benefit in need of intubation and mortality as in...

Effect of Roflumilast on Exacerbation Rate in Patients With Chronic Obstructive Pulmonary Disease (COPD): The HERMES Study (BY217/M2-125)

The aim of the study is to compare the effect of roflumilast on exacerbation rate and pulmonary function in patients with chronic obstructive pulmonary disease (COPD). Roflumilast will be ...

Ultra-wide Fluorescein Angiography in Patients With Central Retinal Vein Occlusion Treated by Afilbercept

In patients with macular edema secondary to CRVO, Aflibercept demonstrated efficacy and safety in 2 parallel trials, interventional phase III studies, COPERNICUS study performed in United ...

Companies [373 Associated Companies listed on BioPortfolio]

HERMES Biosciences

HERMES Biosciences, Inc. was founded in 1998 to develop highly innovative targeted drug delivery technologies for therapeutic and other biomedical applications. The HERMES vision builds upon previous ...

HERMES PHARMA

HERMES PHARMA specializes in developing and manufacturing user-friendly solid oral dosage forms – including effervescent and chewable tablets, instant drinks and orally disintegrating granules...

Hydra Biosciences, Inc.

Hydra Biosciences is a privately-held biopharmaceutical company based in Cambridge, Massachusetts, and develops drugs to treat pain, inflammation, anxiety and other diseases using...

Leadiant Biosciences, Inc.

Leadiant Biosciences, Inc. (formerly Sigma-Tau Pharmaceuticals, Inc.) is a U.S.-based, wholly owned subsidiary of Leadiant Biosciences S.p.A., a research-based pharmaceutical comp...

JeNu Biosciences

JeNu Biosciences was founded in 2008 by a team of ultrasound scientists, medical doctors and beauty executives and is currently led by Wayne Wager, CEO. JeNu Biosciences is a Seat...

More Information about "HERMES Biosciences" on BioPortfolio

We have published hundreds of HERMES Biosciences news stories on BioPortfolio along with dozens of HERMES Biosciences Clinical Trials and PubMed Articles about HERMES Biosciences for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of HERMES Biosciences Companies in our database. You can also find out about relevant HERMES Biosciences Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...


Corporate Database Quicklinks



Searches Linking to this Company Record